Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122346) titled 'A Clinical Study on the Impact of Remimazolam Tosilate for Maintenance of General Anesthesia on Postoperative Recovery Quality' on April 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Min Dong Hospital Affiliated to Fujian Medical University
Condition:
N/A
Intervention:
Group Remimazolam:Remimazolam besylate (concentration: 1 mg·ml-1) was administered via intravenous infusion pump at a rate of 12 mg·kg-1·h?1 for sedation. Upon loss of consciousness (LoC, defined as loss of the eyelash reflex), the infusion rate was adjusted to 1-3 mg·kg-1·h?1 and main...